Abstract
We present a case of a chronic mass-forming pancreatitis (CMFP) detected by 18F-choline (FCH) PET/CT in a male affected by prostate cancer. FCH PET/CT scan showed a focal uptake in the uncinate process of the pancreas, later diagnosed as a CMFP at biopsy. Although the physiological distribution of FCH in the pancreas, a careful interpretation of the images in this area is warranted.
Keywords: fluorocholine, PET/CT, pancreatitis, magnetic resonance imaging, histopathology
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Schillaci O., Calabria F., Tavolozza M., Carmelo C., Marco C., Caracciolo C.R., Roberta D., Antonio O., Giovanni S. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: Experience in 80 patients with prostate cancer. Nucl. Med. Commun. 2010;31:39–45. doi: 10.1097/MNM.0b013e328330adc5. [DOI] [PubMed] [Google Scholar]
- 2.Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012;62:10–29. doi: 10.3322/caac.20138. [DOI] [PubMed] [Google Scholar]
- 3.Issa Y., Kempeneers M.A., van Santvoort H.C., Bollen T.L., Bipat S., Boermeester M.A. Diagnostic performance of imaging modalities in chronic pancreatitis: A systematic review and meta-analysis. Eur. Radiol. 2017;27:3820–3844. doi: 10.1007/s00330-016-4720-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gu X., Liu R. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19–9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly. Clin. Interv. Aging. 2016;11:1365–1370. doi: 10.2147/CIA.S115254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Razpotnik M., Bota S., Essler G., Weber-Eibel J., Peck-Radosavljevic M. Endoscopic ultrasound (EUS) in pancreatic masses with inconclusive radiologic workup–a case series and short review of the literature. Med. Ultrason. 2021;23:107–110. doi: 10.11152/mu-2408. [DOI] [PubMed] [Google Scholar]
- 6.Volmar K.E., Vollmer R.T., Jowell P.S., Nelson R.C., Xie H.B. Pancreatic FNA in 1000 cases: A comparison of imaging modalities. Gastrointest. Endosc. 2005;61:854–861. doi: 10.1016/S0016-5107(05)00364-0. [DOI] [PubMed] [Google Scholar]
- 7.Iglesias-Garcia J., Lindkvist B., Larino-Noia J., Abdulkader-Nallib I., Dominguez-Muñoz J.E. Differential diagnosis of solid pancreatic masses: Contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both? United Eur. Gastroenterol. J. 2017;5:236–246. doi: 10.1177/2050640616640635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hirai K., Watanabe S., Nishijima N., Shibata K., Hase A., Yamanaka T., Inazu M. Molecular and functional analysis of choline transporters and antitumor effects of choline transporter-like protein 1 inhibitors in human pancreatic cancer cells. Int. J. Mol. Sci. 2020;21:5190. doi: 10.3390/ijms21155190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Snider S.A., Margison K.D., Ghorbani P., LeBlond N.D., O’Dwyer C., Nunes J.R.C., Nguyen T., Xu H., Bennett S.A.L., Fullerton M.D. Choline transport links macrophage phospholipid metabolism and inflammation. J. Biol. Chem. 2018;293:11600–11611. doi: 10.1074/jbc.RA118.003180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Van der Hiel B., Stokkel M.P.M.L., Buikhuisen W.A., Janssen H., van Velthuysen M.-L.F., Rhodius R.J., Vogel W.V. 18F-Choline PET/CT as a new tool for functional imaging of non-proliferating secreting neuroendocrine tumors. J. Endocrinol. Metab. 2015;5:267–271. doi: 10.14740/jem300w. [DOI] [Google Scholar]
- 11.Chen B.B., Tien Y.W., Chang M.C., Cheng M.F., Chang Y.T., Wu C.H., Chen X.J., Kuo T.C., Yang S.H., Shih I.L., et al. PET/MRI in pancreatic and periampullary cancer: Correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis. Eur. J. Nucl. Med. Mol. Imaging. 2016;43:1753–1764. doi: 10.1007/s00259-016-3356-y. [DOI] [PubMed] [Google Scholar]